Evidence map›Paper›PMID 39607632›Full record

ArticleProbiotics and antimicrobial proteins2025

Comparative Evaluation of Spores and Vegetative Forms of Bacillus subtilis and Bacillus licheniformis on Probiotic Functionality In Vitro and In Vivo.

Hua Xie, Tianfei Yu, Qiwen Zhou, Kai Na, Shuang Lu, Li Zhang, Xiaohua Guo

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. A ProbioticMicroorganisms · 2026
    Article
  4. Article
  5. Coencapsulation of MultistrainInternational journal of microbiology · 2026
    Article
  6. Article
  7. Article
  8. Microorganisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hua XieCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Tianfei YuCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Qiwen ZhouCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Kai NaCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Shuang LuCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Li ZhangCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China.
Xiaohua GuoCollege of Life Science, South-Central Minzu University, No. 182, Minyuan Road, Hongshan District, Wuhan City, 430074, China. guoxh@mail.scuec.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The probiotic effects of Bacillus are strain-specific and dependent on both spore and vegetative forms, but the distinct contributions of these forms to probiotic functionality are not well understood. This study aimed to evaluate and compare the impacts of vegetative forms and spores of Bacillus subtilis and Bacillus licheniformis on probiotic functions in vitro and in vivo. We systematically assessed the anaerobic metabolic capabilities and the potential to enhance the intestinal barrier function of four Bacillus strains, leading to the selection of Bacillus subtilis X22 and Bacillus licheniformis N-3 for detailed investigation. Utilizing in vitro fermentation with murine fecal microbiota, we observed that the spores form of Bacillus licheniformis N-3 noticeably positively regulated the gut microbiota under anaerobic conditions. Concurrently, both spore and vegetative forms of Bacillus licheniformis N-3 and Bacillus subtilis X22 demonstrated the ability to prevent pathogen adhesion, reduce inflammation, combat oxidative stress, and promote cellular autophagy to reduce apoptosis in response to enterotoxigenic Escherichia coli (ETEC) infection in the IPEC-J2 cell model. As a facultative anaerobe, Bacillus licheniformis N-3 exhibited a tendency toward superior regulatory capacity in enhancing the anti-infective activity of IPEC-J2 cells in vitro. In the pathogens challenge mouse model, B. licheniformis N-3 effectively preserved the integrity of jejunal tissue and enhanced the expression of glycoproteins in goblet cells. Moreover, B. licheniformis N-3 strengthened the epithelial barrier by increasing the levels of Occludin and Claudin-1 in the jejunum, thus promoting overall intestinal health. This research offers new insights into strain selection and the life cycle utilization of Bacillus probiotics.

Indexed as

Bacillus licheniformisBacillus subtilisProbioticsSpores, BacterialAnimalsCell LineFecesFermentationGastrointestinal MicrobiomeMiceBacillusIn vitro fermentationIPEC-J2SporesVegetative forms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.